πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9850468

Infectious hepatitis E virus genotype 3 recombinants

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9845350

Monoclonal antibodies that react with the capsule of bacillus anthracis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9844569

Methods of producing enriched populations of tumor reactive T cells from peripheral blood

The United State of America, as Represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9833519

Methods for the diagnosis and treatment of sjΓΆgren's syndrome

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9833468

Methods for treating progeroid laminopathies using oligonucleotide analogues targeting hum

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9833437

Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphyl

The United States of America as represented by the Secretary of the Army Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9827223

Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agoni

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9822162

Anti-human papillomavirus 16 E6 T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9821029

Methods of reducing salmonella in poultry

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9820965

Biologically active macrolides, compositions, and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9822057

Solid forms of treprostinil

United Therapeutics Corporation Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9815887

Monoclonal antibodies that neutralize a norovirus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9814771

Live attenuated classical swine fever vaccine based in genetic manipulation of a putative

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9809824

CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9809643

Identification of antibodies specific for at least two different lyssaviruses

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9808520

Rationally developed african swine fever attenuated virus strain protects against challeng

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9808458

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9804163

Biomarkers for prostate cancer and methods for their detection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9803022

Mesothelin domain-specific monoclonal antibodies and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9802904

Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9801865

Materials and methods for diagnosis, prevention and/or treatment of stress disorders and c

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9795665

Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9795662

Vaccine comprising AMA1 and RON2

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9795661

TH1/TH2 polarizing vaccines

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted